Optimization of Antigen Dose for a Receptor-Binding Domain-Based Subunit Vaccine Against MERS Coronavirus

Human Vaccines and Immunotherapeutics - United States
doi 10.1080/21645515.2015.1021527
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Informa UK Limited

Related search

Spiking the MERS-coronavirus Receptor

Cell Research
Cell BiologyMolecular Biology
2013English

A Humanized Neutralizing Antibody Against MERS-CoV Targeting the Receptor-Binding Domain of the Spike Protein

Cell Research
Cell BiologyMolecular Biology
2015English

Potential for Developing a SARS-CoV Receptor-Binding Domain (RBD) Recombinant Protein as a Heterologous Human Vaccine Against Coronavirus Infectious Disease (COVID)-19

Human Vaccines and Immunotherapeutics
MedicineAllergyImmunologyPharmacology
2020English

Crystal Structure of NL63 Respiratory Coronavirus Receptor-Binding Domain Complexed With Its Human Receptor

2009English

High Antigen Dose Is Detrimental to Post-Exposure Vaccine Protection Against Tuberculosis

Frontiers in Immunology
AllergyImmunology
2018English

Structural Definition of a Unique Neutralization Epitope on the Receptor-Binding Domain of MERS-CoV Spike Glycoprotein

Cell Reports
BiochemistryGeneticsMolecular Biology
2018English

The S2 Subunit of the Murine Coronavirus Spike Protein Is Not Involved in Receptor Binding.

Journal of Virology
Insect ScienceImmunologyMicrobiologyVirology
1995English

Structure of Severe Acute Respiratory Syndrome Coronavirus Receptor-Binding Domain Complexed With Neutralizing Antibody

Journal of Biological Chemistry
BiochemistryCell BiologyMolecular Biology
2006English

Crystal Structure of the Receptor-Binding Domain From Newly Emerged Middle East Respiratory Syndrome Coronavirus

Journal of Virology
Insect ScienceImmunologyMicrobiologyVirology
2013English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy